Summary Information:
Merck & Company Inc. Common Stock (new)
NYSE:MRK


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Merck & Company Inc. Common Stock (new)
Exchange: NYSE
Symbol: MRK
SEC CIK: 0000310158
Phone: 908-740-4000
2000 GALLOPING HILL ROAD
KENILWORTH NJ 07033

CEO: Kenneth Frazier
Price when page updated: 100.24 Date: 2023-12-03
Company Website:
www.merck.com

_Description: For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of its mission to save and improve lives. It demonstrates its commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to prevent and treat diseases that threaten people and animals - including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases - as we aspire to be the premier research-intensive biopharmaceutical company in the world.

IPO YEAR:

Sector:
Health Care
Industry:
Biotechnology: Pharmaceutical Preparations
ADRTSO:

MarketCap:
254010473940.00
Beta:
0.2306464028417583
52 Week High:
91.4
52 Week Low:
15.32
52 Week Change:
0.011456880715700724
Short Interest:

Short Date:

Shares Outstanding:
2525943936
Dividend Rate:
2.604796810545311
Dividend Yield:
8.13%
ExDividend Date:
2021-12-14
Latest EPS:

Latest EPS Date:
27 Oct 2022
Float:
0
return on Equity:
-99.00%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$4.564B
ttmEPS:
2.77
Revenue:
$25.476B
Gross Profit:

Cash:

Debt:

Institution Percent:
60.20%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.07%
Return on Assets:
4.50%
Return on Capital:

Profit Margin:
6.80%
Price to Sales:
3.26
Price To Book:
-
Short Ratio:
2.17
PE Ratio:
28.566053017187325
Employees:
73500
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__Merck & Company Inc. Common Stock (new) [ MRK ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-03